ReviewCJC open2026
New Insights in Exercise for Arrhythmogenic Cardiomyopathy: A Narrative Review.
Review in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes: The Importance of Shared Decision-Making and an Individualized Approach.JACC. Case reports · 2026Article
- Exercise testing in athletes: an adjunct to diagnose arrhythmogenic cardiomyopathy?Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiac condition and an important cause of sudden cardiac death among athletes. ACM may result in ventricular dysfunction with a high rate of ventricular arrhythmia disproportionate to the degree of cardiac chamber dilatation or dysfunction. Although ACM is genetically mediated for the most part, exercise has been recognized as a key modulator in its prognosis and outcomes. Several knowledge gaps exist surrounding the interaction between this condition and exercise. ACM is a heterogeneous condition with certain genotype-phenotype correlations that may result in differential impact of exercise. In addition, ACM patients traditionally have been relegated to participate in only low-intensity exercise, but this advice lacks objectivity and clear definitions, and no safe exercise thresholds have been proposed. Finally, no consensus has been reached on which exercise advice is to be given for genotype-positive phenotype-negative family members. The aim of this review is to address these concerns, propose a practical approach for exercise prescription in ACM, and provide an up-to-date literature review of the impact of exercise on the various subtypes of ACM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.